| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.5M | — | +47.8% |
| Cost of Revenue | $1.9M | — | +14.2% |
| Gross Profit | $4.5M | — | +69.2% |
| R&D Expense | $2.0M | — | -20.4% |
| SG&A Expense | $968K | — | -33.4% |
| Operating Income | -$46K | — | +98.5% |
| Pre-tax Income | $1.1M | — | +131.7% |
| Net Income | $1.1M | — | +131.7% |
| EPS (Basic) | $0.06 | — | +117.6% |
| EPS (Diluted) | $0.06 | — | +117.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $4.0M | +118.4% | +106.0% |
| Inventory | $1.8M | +9.3% | +0.4% |
| Current Assets | $9.7M | +19.1% | -6.4% |
| Total Assets | $20.6M | +5.6% | -7.6% |
| Current Liabilities | $7.9M | +1.1% | +11.3% |
| Total Liabilities | $17.5M | -0.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | -214.0% | +44.6% |
| Capital Expenditures | $63K | — | +33.5% |
| Investing Cash Flow | -$63K | — | -33.5% |
| Financing Cash Flow | $383K | — | -18.7% |
| Free Cash Flow | -$1.3M | — | +43.0% |
| -0.9% |
| Stockholders' Equity | -$16.9M | +6.9% | -10.0% |